Wolters Kluwer unit to get new CEO

Wolters Kluwer Pharma Solutions will get a new CEO following the retirement of the pharmacy data and analytics firm's former head honcho, Mark Spiers, in April.
As interim CEO, the company named Robert Becker, who currently heads up sister company Wolters Kluwer Health. Becker will run both units until a permanent replacement for Spiers is found, said a source.
Becker has been CEO of Wolters Kluwer's Health division since 2008, after a five-year stint with the parent company that included running a unit of the Dutch conglomerate's Tax, Accounting & Legal division.
Spiers is joining the board of directors of Qforma, which provides advanced analytics and predictive modeling technologies for the health sciences industry, Qforma said in an announcement.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.